Optimizing AAV and LV Purification and Analytics: Accelerated High-Quality Processes using CIM® Monoliths and PATfix®
Discover Hana Jug’s recorded presentation from BPI East 2025 on optimizing AAV and LV purification and analytics using CIM Monoliths and PATfix for accelerated, high-quality processes.
Speaker:
Hana Jug, Product Manager for Enveloped viruses, VLPs and EVs, Sartorius BIA Separations
Watch the webinar to learn how to:
- Achieve high purity standards in AAV and LV applications, ensuring effective impurity elimination.
- Utilize CIM® Monoliths for enhanced purification processes in cell and gene therapy.
- Leverage PATfix for complementary analytics, assessing recovery and impurity removal.
Abstract:
AAV and Lentiviral vectors are essential in cell and gene therapy, requiring high purity and effective impurity elimination. CIM® Monoliths are crucial for achieving these purity standards, while PATfix provides complementary analytics to assess recovery and monitor impurity removal. Together, they offer a comprehensive understanding of sample composition, enhancing the efficiency and quality of biopharmaceutical production. Hana Jug’s presentation explores these advanced strategies, providing valuable insights for optimizing purification and analytics processes.